Brandström, J., Vetander, M., Sundqvist, A., Lilja, G., Johansson, S. G. O., Melén, E., . . . Nilsson, C. (2019). Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents. Clinical and experimental allergy, 49(10), 1328-1341. https://doi.org/10.1111/cea.13469
Chicago Style (17th ed.) CitationBrandström, Josef, Mirja Vetander, Ann‐Charlotte Sundqvist, Gunnar Lilja, S. G. O. Johansson, Erik Melén, Eva Sverremark‐Ekström, Anna Nopp, and Caroline Nilsson. "Individually Dosed Omalizumab Facilitates Peanut Oral Immunotherapy in Peanut Allergic Adolescents." Clinical and Experimental Allergy 49, no. 10 (2019): 1328-1341. https://doi.org/10.1111/cea.13469.
MLA (9th ed.) CitationBrandström, Josef, et al. "Individually Dosed Omalizumab Facilitates Peanut Oral Immunotherapy in Peanut Allergic Adolescents." Clinical and Experimental Allergy, vol. 49, no. 10, 2019, pp. 1328-1341, https://doi.org/10.1111/cea.13469.